About Steven Thornton
Form D filings for Aerami Therapeutics from 2017 to 2023 list Steven Thornton as director.
Steven Thornton first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Thornton in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Thornton works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D, Nov 22, 2023
GB
Gary Burgess
Chief Medical Officer
AW
Anne Whitaker
Chief Executive Officer, Chairwoman of the Board
AS
Adam Stern
Director
JP
John Patton
Director
WW
William Welch
Director
JZ
Joshua Ziel
Chief Operating Officer
DH
Darlene Deptula-Hicks
Chief Financial Officer and Director